Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 25, 1356-1360, September 1, 1965]
© 1965 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haenszel, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haenszel, W.

Multiple Factors: Discussion of Statistical and Epidemiologic Aspects

William Haenszel

National Cancer Institute, USPHS, Bethesda, Maryland

One can be optimistic about the contributions which the statistical-epidemiologic approach will make to future studies of multiple factors in cancer etiology. The epidemiologic method can lend itself to the study of both host characteristics and environmental factors. However, cancer epidemiology has not completely left the descriptive phase behind, and emphasis still needs to be placed on identification of factors associated with gradients in risk. As the fund of information on variations in cancer risk among population groups grows, more and more questions will be posed that that will lead to investigations of multiple factors. Epidemiologic observations should foster certain lines of experimental work, the findings from which can later be incorporated into more refined epidemiologic studies, thus continuing and sustaining the interaction between epidemiology and experimental carcinogenesis.

Above all, investigators should not be deterred by possible imperfections in the data they can collect. It is better to do what can be done today, but with an eye to the future and recognizing that current, imperfect data are to some degree self-perfecting as provisional findings are introduced into the design and pursuit of new studies.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1965 by the American Association for Cancer Research.